Mapping peripheral blood glycoprotein profiles of COVID-19 sufferers

In a just lately printed research on the medRxiv* pre-print server, a crew of researchers analyzed differential protein glyco-isoform distributions of symptomatic and asymptomatic coronavirus illness 2019 (COVID-19) sufferers. 

Study: Differential Peripheral Blood Glycoprotein Profiles in Symptomatic and Asymptomatic COVID-19. Image Credit: Corona Borealis Studio/ShutterstockResearch: Differential Peripheral Blood Glycoprotein Profiles in Symptomatic and Asymptomatic COVID-19. Picture Credit score: Corona Borealis Studio/Shutterstock

A number of biomarkers, together with interleukin 6 (IL-6) and C-reactive protein (CRP), have been studied for his or her potential to foretell a roughly extreme scientific course of COVID-19, however to date none have confirmed absolutely efficient in managing COVID-19-infected sufferers. General, there’s appreciable heterogeneity throughout research reporting the outcomes noticed with COVID-19. Furthermore, a number of research up to now have interrogated plasma glycoprotein isoforms within the context of extreme bacterial sepsis, however none have mentioned related adjustments within the context of COVID-19.

Concerning the research

The current research analyzed the differential protein glycosylation profiles of severely sick and asymptomatic COVID-19 sufferers. For extra reference and to watch the distinction between two systemic inflammatory syndromes, the research additionally analyzed glycoproteome profiles of people with bacterial sepsis.

The researchers analyzed a complete of 597 distinctive biomarkers, of which 531 have been plentiful serum glycopeptides (concentrations of >10 µg/ml) and 66 have been non-glycosylated peptides. A complete of 72 samples, together with 50 (39 serum, 11 plasma) from sufferers hospitalized with PCR-confirmed extreme symptomatic COVID-19 and 22 serum samples from people with no historical past of symptomatic COVID-19 sickness have been analyzed through the research. Of the 72 COVID-19 sufferers, symptomatic COVID-19 sufferers have been on common 10 years older than asymptomatic COVID-19 topics, and 25 have been male. Sepsis sufferers have been on common, 66.5 years outdated and 11 of the 16 have been male. 

For extra reference, samples from 12 people with a historical past of an infection with a typical chilly coronavirus, 16 people with bacterial sepsis, and 15 wholesome topics with no prior publicity to extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been additionally analyzed.

The authors used a glycoprotein profiling expertise platform that coupled liquid chromatography (LC) and mass spectrometry (MS) for the analyses. This enabled them to precisely determine and quantify glycoproteomic signatures extremely predictive of a spread of scientific circumstances.


The evaluation revealed statistically totally different glycoprotein profiles, at a false discovery charge (FDR) <0.05, between symptomatic and asymptomatic COVID-19 sufferers. Of the 597 peptides and glycopeptides studied, 374 have been plentiful in symptomatic COVID-19 sufferers. It’s price noting right here that variations of any biomarker have been thought-about statistically important in the event that they glad an FDR of lower than 0.05 amongst phenotype teams in contrast.

The respective principal part evaluation and heatmaps of glycoprotein abundance profiles of symptomatic COVID-19 and sepsis sufferers confirmed placing similarities. A subset of 34 glycoforms differentiated symptomatic COVID-19 and sepsis sufferers from different samples, thus representing a singular signature of symptomatic COVID-19.

Amongst symptomatic COVID-19 circumstances and sepsis sufferers, 101 glycopeptide and peptide biomarkers have been statistically considerably plentiful. Of those 101 biomarkers, 65 have been greater and 36 have been decrease in abundance in COVID-19 sufferers, in comparison with sepsis sufferers, indicating the distinctive attributes of the 2 phenotypes. Of the full 66 non-glycosylated peptides assayed through the research, 25 have been statistically considerably downregulated in each symptomatic COVID-19 and sepsis with FDR of lower than 0.05. The evaluation additionally confirmed that the APOC3 peptide, GWVTDGFSSLK, was barely decreased in septic sufferers, in comparison with wholesome controls; nevertheless, with a fold change of 0.956 and FDR of 0.903, it didn’t attain statistical significance.

In sepsis and COVID-19, a number of anti-inflammatory mediators akin to tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), IL-6, and monocyte chemoattractant protein 1 (MCP1) are launched. That is adopted by an increase within the ranges of a number of acute-phase proteins akin to procalcitonin, calprotectin, proadrenomedullin, pentraxin-3, and CRP.

The bioinformatic evaluation highlighted the activation of the complement cascade and different pathways concerned with acute section response signaling and the coagulation system in samples of symptomatic COVID-19 sufferers. The outcomes confirmed many statistically considerably altered members of the complement cascade pathway, together with C3, C5, and C6, essential in mediating immune response to SARS-CoV-2 an infection. The adjustments in acute-phase proteins and anti inflammatory mediators, such because the IL-6 cytokine, indicated a correlation with COVID-19-infection and the danger of respiratory failure.

Notably, the evaluation couldn’t sufficiently quantify or statistically assess the associations of symptomatic COVID-19 and sepsis severity with each hyper-sialylation and hyper-fucosylation of glycopeptides within the absence of bigger within-group pattern sizes.


The research findings demonstrated that a lot of the noticed glycoprotein modifications have been generic and therefore shared amongst symptomatic COVID-19 and sepsis sufferers. Nonetheless, some glyco-isoform adjustments have been both particular to extreme COVID-19 an infection or indicated a predisposition in direction of creating extreme sickness.

To conclude, the research findings reiterated the worth of glycoproteomic biomarkers within the scientific administration of all acute infectious circumstances together with COVID-19.

*Vital discover

medRxiv publishes preliminary scientific experiences that aren’t peer-reviewed and, due to this fact, shouldn’t be thought to be conclusive, information scientific apply/health-related habits, or handled as established data.

#Mapping #peripheral #blood #glycoprotein #profiles #COVID19 #sufferers

Leave a Comment